Charity D. Scripture
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Drug Transport and Resistance Mechanisms
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 9
- Lung Cancer Research Studies 5
- Peptidase Inhibition and Analysis 4
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- William D. Figg (12 shared papers)Alex Sparreboom (8 shared papers)John A. Pieper (1 shared paper)Michael Hawkins (2 shared papers)Neil Desai (2 shared papers)Andrew Yang (1 shared paper)Tapas De (1 shared paper)Paul J. Williams (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Cancer Research (3 papers)Nature reviews. Cancer (2 papers)Annals of Oncology (2 papers)Current Neuropharmacology (1 paper)
- Partner nations
- United StatesJapanNetherlands
In The Last Decade
Charity D. Scripture
25 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Oncology 757
- Pharmacology 219
- Biomaterials 320
- Geriatrics and Gerontology 55
- Cancer Research 194
Countries citing papers authored by Charity D. Scripture
This map shows the geographic impact of Charity D. Scripture's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charity D. Scripture with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charity D. Scripture more than expected).
Fields of papers citing papers by Charity D. Scripture
This network shows the impact of papers produced by Charity D. Scripture. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charity D. Scripture. The network helps show where Charity D. Scripture may publish in the future.
Co-authors
The 25 scholars most cited alongside Charity D. Scripture, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 403 | |
| 2 | 2006 | 278 | |
| 3 | 2006 | 253 | |
| 4 | 2008 | 189 | |
| 5 | 2008 | 142 | |
| 6 | 2001 | 142 | |
| 7 | 2005 | 95 | |
| 8 | 2006 | 76 | |
| 9 | 2005 | 60 | |
| 10 | 2005 | 24 | |
| 11 | 2019 | 23 | |
| 12 | 2024 | 18 | |
| 13 | 2004 | 15 | |
| 14 | 2006 | 15 | |
| 15 | 2008 | 13 | |
| 16 | 2005 | 11 | |
| 17 | 2019 | 11 | |
| 18 | 2005 | 9 | |
| 19 | 2006 | 6 | |
| 20 | 2005 | 3 |
About Charity D. Scripture
Charity D. Scripture is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology and Epidemiology, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Pharmacogenetics and Drug Metabolism (5 papers), Lung Cancer Research Studies (5 papers), Prostate Cancer Treatment and Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Oncology (757 citations), Pharmacology (219 citations), Biomaterials (320 citations), Geriatrics and Gerontology (55 citations) and Cancer Research (194 citations). Charity D. Scripture has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include William D. Figg, Alex Sparreboom, John A. Pieper, Michael Hawkins, Neil Desai, Andrew Yang, Tapas De, Paul J. Williams, Vuong Trieu and William L. Dahut. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Nature reviews. Cancer, Annals of Oncology and Current Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.